LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co stock buybacks 1989–2026

Eli Lilly & Co spent 377.00M USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, down 46.8% on the same quarter a year before. Eli Lilly & Co spent 5.84B USD buying back its shares over the last twelve months, up 25.5% on the twelve months before. In fiscal year 2025 it spent 4.11B USD, up 64.3% on the year before.

Last updated 10 Nov 2026 · Next report 3 Feb 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 20265.84B+25.51%5.98B19.66B
FY202531 Dec 20254.11B+64.32%5.38B8.97B
FY202431 Dec 20242.50B+233.33%4.68B3.76B
FY202331 Dec 2023750.00M-50.00%4.07B-3.15B
FY202231 Dec 20221.50B+20.00%3.54B4.60B
FY202131 Dec 20211.25B+150.00%3.09B5.39B
FY202031 Dec 2020500.00M-88.64%2.69B4.47B
FY201931 Dec 20194.40B+6.01%2.41B3.48B
FY201831 Dec 20184.15B+1,284.49%2.31B2.51B
FY201731 Dec 2017299.80M-50.04%2.19B3.45B
FY201631 Dec 2016600.10M-19.93%2.16B3.76B
FY201531 Dec 2015749.50M-6.31%2.13B1.34B
FY201431 Dec 2014800.00M-52.89%2.10B2.89B
FY201331 Dec 20131.70B+135.49%2.12B4.64B
FY201231 Dec 2012721.10M—2.19B4.26B
FY201131 Dec 20110.00—2.18B5.54B
FY201031 Dec 20100.00—2.17B5.67B
FY200931 Dec 20090.00—2.15B3.48B
FY200831 Dec 20080.00—2.06B6.35B
FY200731 Dec 20070.00-100.00%1.85B4.07B
FY200631 Dec 2006122.10M-67.69%1.74B2.90B
FY200531 Dec 2005377.90M—1.65B615.50M
FY200431 Dec 20040.00-100.00%1.54B971.40M
FY200331 Dec 2003281.10M-27.02%1.44B1.94B
FY200231 Dec 2002385.20M-29.41%1.34B939.80M
FY200131 Dec 2001545.70M-48.17%1.21B2.78B
FY200031 Dec 20001.05B-27.54%1.13B3.05B
FY199931 Dec 19991.45B-33.12%1.00B2.09B
FY199831 Dec 19982.17B+518.45%877.70M2.21B
FY199731 Dec 1997351.30M+11.70%818.00M2.03B
FY199631 Dec 1996314.50M+101.60%753.20M1.55B
FY199531 Dec 1995156.00M+40.54%747.20M1.27B
FY199431 Dec 1994111.00M+330.23%723.10M955.80M
FY199331 Dec 199325.80M-62.34%708.40M883.40M
FY199231 Dec 199268.50M-1.01%643.70M481.40M
FY199131 Dec 199169.20M-93.52%582.70M112.20M
FY199031 Dec 19901.07B+471.00%450.10M467.10M
FY198931 Dec 1989186.90M—372.00M478.10M

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Eli Lilly & Co's buybacks

Source: Financial Modeling Prep